We believe that FAIM2 alone or combined with other existing NE markers can improve diagnostic accuracy in SCLC and other NE tumors but to validate the significance of FAIM2 as a diagnostic marker of SCLC a larger validation study will be necessary. This evidence concerns the gene FAIM2 and small cell lung carcinoma.